Welcome to our dedicated page for Aflac news (Ticker: AFL), a resource for investors and traders seeking the latest updates and insights on Aflac stock.
Aflac Incorporated (NYSE: AFL) is a Fortune 500 insurer in the direct life and supplemental health insurance space, with major operations in the United States and Japan. The AFL news feed on Stock Titan brings together company-issued updates and market-moving announcements that reflect how Aflac manages its insurance business, capital, partnerships and community initiatives.
Recent Aflac news has covered a range of topics, including quarterly and annual earnings releases, dividend declarations and conference call schedules where management discusses financial results. These items provide insight into segment performance for Aflac U.S. and Aflac Japan, trends in net earned premiums and adjusted earnings, and the company’s approach to capital deployment through dividends and share repurchases.
News stories also highlight Aflac’s strategic partnerships and product-related initiatives. Examples include collaborations to integrate Aflac’s supplemental health products with benefits technology platforms and administrative partners, particularly in the public sector market and employer benefits space. Such announcements illustrate how Aflac connects its supplemental health offerings with employer-sponsored benefits and consumer-directed health care administration.
Aflac’s communications frequently emphasize its role in workplace benefits trends through the Aflac WorkForces Report, which examines employee stress, burnout, financial fragility and the perceived value of supplemental insurance. Other articles focus on the company’s philanthropic efforts, such as support for the Aflac Childhood Cancer Foundation, the My Special Aflac Duck® program and the “Beyond Words” children’s book, all aimed at assisting children and families facing cancer and blood disorders.
Investors and observers following AFL news can use this page to monitor earnings announcements, dividend decisions, risk disclosures, benefits-related research and community initiatives that shape Aflac’s profile as a supplemental health and life insurer. Bookmark this feed to review new press releases and regulatory-related communications as they are issued by the company.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Aflac Incorporated (NYSE: AFL) reported first-quarter 2023 results with total revenues of $4.8 billion, down from $5.2 billion year-over-year. Net earnings rose to $1.2 billion or $1.94 per diluted share, compared to $1.0 billion or $1.60 per share last year. Adjusted earnings increased to $953 million, up 1.2%, with adjusted earnings per diluted share at $1.55, reflecting a 7.6% increase. However, net earned premiums in Aflac Japan fell 17.3%, while Aflac U.S. saw a modest increase of 1.1%. The company declared a $0.42 dividend for Q2 2023 and announced a $700 million share repurchase plan. Aflac maintains a solid capital position despite challenges from currency exchange rates.
Aflac Incorporated's Chairman and CEO, Daniel P. Amos, was honored as a 2023 Georgia Trustee, recognizing his philanthropic efforts and leadership within the state. The award was presented by the Georgia Historical Society and U.S. Senator Raphael Warnock. Aflac's commitment to childhood cancer support is highlighted, with over $167 million contributed to the Aflac Cancer and Blood Disorders Center. The center is renowned nationally for its pediatric care. Amos has also spearheaded initiatives like the My Special Aflac Duck social robot, providing comfort to children in treatment, and establishing Aflac Parents House in Japan, supporting over 149,000 families. Aflac is recognized as a leader in supplemental health insurance in the U.S. and cancer insurance in Japan, maintaining a strong ethical and sustainable business practice.